Home › Peripheral Arterial Disease › Tennessee
Peripheral Arterial Disease clinical trials in Tennessee
14 studies for Peripheral Arterial Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Apex Research Foundation, LLC, Jackson
- Tennova TCMC, Knoxville
- Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- The Jackson Clinic, Jackson
- East Coast Institute for Research - Jefferson City, Jefferson City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Tennessee Center for Clinical Trials, Tullahoma
Recruiting
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06321575The THOR IDE Study
- Vascular Institute of Chattanooga, Chattanooga
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05916950The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Wellmont Holston Valley Medical Center, Kingsport
Recruiting
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT05811364REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
- University of Tennessee Medical Center, Knoxville
Recruiting
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT07223437SELUTION4BTK Trial
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT05055297PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 95 · All sexes · Updated Apr 16, 2026 · NCT05313165Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159Randomized Clinical Trial for Ewing Amputation in the VA
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Recruiting
All ages · All sexes · Updated Feb 9, 2026 · NCT05437562Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
- Wellmont CVA Heart Institute, Kingsport
RecruitingObservational study
All ages · All sexes · Updated Feb 6, 2026 · NCT01904851Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198Pounce™ Thrombectomy System Retrospective Registry
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 11, 2025 · NCT05868161From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.